Quantum Biopharma-B Sub VotQNTM
13F holders, Q3 2025 (September 30)17holders
4new positions
4sold out
$13.21avg. 13F price*
At the end of Q3 2025, 17 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings, unchanged from Q2 2025. 4 opened new positions and 4 sold out. The largest holders were AdvisorShares Investments LLC ($611K), UBS Group AG ($144K) and Steward Partners Investment Advisory, LLC ($51K).
- Company
- Quantum Biopharma-B Sub Vot
- CUSIP
- 74764Y205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $6K |
| Exits | 4 | $584K |
All 13F filers, Q2 2025 → Q3 2025: 17,435 shares bought and 66,158 shares sold, net −48,723 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| AdvisorShares Investments LLC | 0.10% | Add +0.7% | 37,237 | $611K |
| UBS Group AG | 0.00% | Reduce -80.9% | 8,754 | $144K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 3,100 | $51K |
| Morgan Stanley | 0.00% | Add +1857.3% | 2,564 | $42K |
| JPMorgan Chase & Co. | 0.00% | Reduce -17.9% | 736 | $12K |
| Osaic Holdings, Inc. | 0.00% | Add +750.0% | 680 | $11K |
| Royal Bank of Canada | 0.00% | Add +611.0% | 583 | $10K |
| Cetera Trust Company, N.A | 0.00% | No change | 250 | $4K |
| Marex Group Ltd | 0.00% | New | 13,436 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 155 | $3K |
| Bank of America Corp. | 0.00% | New | 100 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +228.6% | 92 | $1K |
| Group One Trading LLC | 0.00% | No change | 34 | $558 |
| Rockefeller Capital Management L.P. | 0.00% | New | 30 | $492 |
| National Bank of Canada | 0.00% | New | 24 | $393 |
| Activest Wealth Management | 0.00% | No change | 15 | $246 |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -33.3% | 2 | $33 |
"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.